Dice CEO: Energy, T...
Health Care: Health Services
AngioDynamics Inc. (ANGO: NASDAQ)
$11.90 -0.14 | -1.16%
06/01/12 - 04:00 PM ET
Ratio Comparisons
| Company | Industry | S&P 500 | |
| Valuation Ratios | |||
|---|---|---|---|
| P/E Ratio (TTM) | 396.70 | 15.40 | 17.70 |
| P/E High - Last 5 Yrs | n.a. | 49.90 | 67.70 |
| P/E Low - Last 5 Yrs | n.a. | 15.50 | 12.50 |
| Beta | 0.70 | 0.77 | 0.98 |
| Price to Sales (TTM) | 1.36 | 1.97 | 1.42 |
| Price to Book (MRQ) | 0.73 | 2.14 | 2.41 |
| Price to Tangible Book (MRQ) | 1.44 | 7.49 | 5.08 |
| Price to Cash Flow (TTM) | 20.60 | 10.50 | 9.80 |
| Price to Free Cash Flow (TTM) | 14.30 | 58.60 | 17.40 |
| Dividends | |||
| Dividend Yield (%) | 0.00 | 1.10 | 2.10 |
| Dividend Yield - 5 Yr Avg (%) | n.a. | 1.00 | 2.20 |
| Dividend 5 Yr Growth Rate (%) | n.a. | 8.98 | -0.76 |
| Payout Ratio (TTM) | 0.00 | 17.00 | 30.00 |
| Sales (MRQ) vs Qtr 1 Yr Ago (%) | -5.60 | 10.90 | 11.80 |
| Sales (TTM) vs TTM 1 Yr Ago (%) | -0.10 | -11.40 | 9.20 |
| Growth Rates (%) | |||
| Sales - 5 Yr Growth Rate (%) | 14.55 | 12.06 | 1.79 |
| EPS (MRQ) vs Qtr 1 Yr Ago (%) | -100.00 | 8.70 | 17.50 |
| EPS (TTM) vs TTM 1 Yr Ago (%) | -100.00 | 8.70 | 17.50 |
| EPS - 5 Yr Growth Rate (%) | n.a. | n.a. | -1.66 |
| Capital Spending - 5 Yr Growth Rate (%) | -14.48 | 6.33 | -1.17 |
| Financial Strength | |||
| Quick Ratio (MRQ) | 5.80 | 1.80 | 1.10 |
| Current Ratio (MRQ) | 7.20 | 2.70 | 1.60 |
| LT Debt to Equity (MRQ) | 0.01 | 0.32 | 0.82 |
| Total Debt to Equity (MRQ) | 0.02 | 0.34 | 0.96 |
| Interest Coverage (TTM) | 1.70 | 11.50 | 5.50 |
| Profitability Ratios (%) | |||
| Gross Margin (TTM) | 59.60 | 59.90 | 46.90 |
| Gross Margin - 5 Yr Avg | 61.40 | 59.90 | 47.70 |
| EBITD Margin (TTM) | 13.50 | 23.80 | 18.90 |
| EBITD - 5 Yr Avg | 12.47 | 0.00 | 0.00 |
| Pre-Tax Margin (TTM) | 0.20 | 15.40 | 12.10 |
| Pre-Tax Margin - 5 Yr Avg | 6.10 | 11.90 | 10.30 |
| Management Effectiveness (%) | |||
| Net Profit Margin (TTM) | 0.00 | 0.13 | 0.09 |
| Net Profit Margin - 5 Yr Avg | 3.50 | 8.70 | 7.00 |
| Return on Assets (TTM) | 0.20 | 7.60 | 3.10 |
| Return on Assets - 5 Yr Avg | 1.60 | 5.20 | 2.50 |
| Return on Investment (TTM) | 0.30 | 10.20 | 7.90 |
| Return on Investment - 5 Yr Avg | 1.70 | 7.20 | 6.50 |
| Efficiency | |||
| Revenue/Employee (TTM) | 305,152.00 | 296,359.00 | 449,376.00 |
| Net Income/Employee (TTM) | 1,486.00 | 40,294.00 | 39,003.00 |
| Receivable Turnover (TTM) | 8.00 | 6.00 | 7.60 |
| Inventory Turnover (TTM) | 3.10 | 2.90 | 8.30 |
| Asset Turnover (TTM) | 0.50 | 0.60 | 0.40 |
Portfolios with ANGO
- Portfolio NameUser Type
- UserMedical devices M&A
- ContributorEarnings Short Squeeze Play...
- ContributorBarron's Insider Purchases ...
- ContributorBarron's Insider Purchases ...
- UserLast Day of the JPMorgan He...
- UserDrewski2 Portfolio 1
- Userwafessler Portfolio 1
- UserRPavlovic Portfolio 1
- UserGluck Portfolio 1
- Userchappervester Portfolio 1
Latest ANGO Headlines from TheStreet
- 5 Stocks That Make Prime Acquisition Targets 05.22.12 | 08:05 am
- AngioDynamics' CEO Discusses Q3 2012 Results - Earnings Call Transcript 04.04.12 | 08:04 pm
- AngioDynamics Inc. Stock Downgraded (ANGO) 03.09.12 | 04:03 am
- AngioDynamics Inc. Presents At The 30th Annual JPMorgan Chase Healthcare Conference, Jan-12-2012 10:30 AM 01.12.12 | 08:01 pm
- AngioDynamics Inc. Stock Upgraded (ANGO) 01.09.12 | 05:01 am
- AngioDynamics' CEO Discusses Q2 2012 Results - Earnings Call Transcript 01.05.12 | 10:01 pm
- AngioDynamics Inc. Stock Downgraded (ANGO) 11.29.11 | 06:11 am
- AngioDynamics Inc. Stock Upgraded (ANGO) 10.26.11 | 07:10 am
- AngioDynamics' CEO Discusses Q1 2012 Results - Earnings Call Transcript 10.06.11 | 09:10 pm
- 5 Earnings Stocks to Squeeze the Bears 10.04.11 | 01:10 pm
Press Releases for ANGO
- NanoKnife® System Clinical Experience Featured At Society Of Surgical Oncology Conference - Business Wire 04.02.12 | 06:04 am
- Five Oral Presentations On Clinical Experience With NanoKnife® System Featured At Society Of Interventional Radiology Conference - Business Wire 03.29.12 | 06:03 am
- AngioDynamics Establishes Strategic Relationship With Microsulis Medical Ltd. - Business Wire 03.26.12 | 06:03 am
- Scott Solano To Depart AngioDynamics - Business Wire 09.22.11 | 04:09 pm
- AngioDynamics Names Joseph M. DeVivo President And CEO - Business Wire 08.16.11 | 07:08 am
- AngioDynamics Reports Fiscal 2011 Fourth Quarter And Full Year Financial Results - Business Wire 07.14.11 | 04:07 pm
- AngioDynamics To Report Fiscal 2011 Fourth Quarter And Full Year Financial Results And Hold Conference Call On July 14, 2011 - Business Wire 07.05.11 | 06:07 am
- AngioDynamics Reports Preliminary Fiscal 2011 Fourth Quarter Financial Results And Corporate Developments - Business Wire 06.13.11 | 04:06 pm
- AngioDynamics Launches VenaCure® 1470nm Laser For Treatment Of Varicose Veins - Business Wire 05.31.11 | 06:05 am
- AngioDynamics Expands VenaCure EVLT® System For Varicose Veins With Longer 90 Cm Kit - Business Wire 05.26.11 | 06:05 am
Partner Headlines for ANGO
- The Zacks Analyst Blog Highlights: AngioDynamics, J.P. Morgan, Bank of America, KeyCorp and CR Bard - Press Releases - Zacks 05.24.12 | 09:05 am
- ANGO Mixed, Adjusts View - Analyst Blog - Zacks 04.05.12 | 09:04 am
- 6 Insider Stock Picks Rated Buy By Canaccord Genuity - Seeking Alpha 02.10.12 | 05:02 pm
- AngioDynamics Cuts View on Recall - Analyst Blog - Zacks 01.27.12 | 07:01 pm
- AngioDynamics Beats, Tweaks View - Analyst Blog - Zacks 01.06.12 | 09:01 am
- November's Low Price To Book Stocks Vs. Bankruptcy Risks - Seeking Alpha 11.04.11 | 08:11 am
- BSD Promotes Hyperthermia Tech - Analyst Blog - Zacks 10.31.11 | 07:10 pm
- Bard's 3Q Mixed, Buying Medivance - Analyst Blog - Zacks 10.26.11 | 09:10 am
- AngioDynamics Trades Lower on Q1 Earnings Results - Benzinga 10.06.11 | 04:10 pm
- Company News for June 16, 2011 - Corporate Summary - Zacks 06.16.11 | 10:06 am
